FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 1918-79-2, stock 229.5g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 19432-69-0, stock 667.4g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 108499-32-7, stock 609.5g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 53899-17-5, stock 334.2g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 1423018-14-7, stock 877g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 1423018-15-8, stock 148.5g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 1292290-97-1, stock 994.9g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 1423018-16-9, stock 842.2g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 148-24-3, stock 844.5g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| LY-2922470, 1423018-12-5, LY-2922470 Intermediate 938-33-0, stock 636.7g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
